Are there any body fluid markers of brain atrophy in multiple sclerosis?

Abstract

The weak correlation between inflammatory activity and disease progression in patients with multiple sclerosis has shifted the emphasis from inflammatory monitoring to the investigation of the pathological processes of demyelination, axonal loss, and gliosis. New magnetic resonance imaging (MRI) techniques that have been developed to measure these processes appear very promising. This paper will briefly discuss potential body fluid markers of axonal loss, gliosis and demyelination, as the pathological substrates of brain atrophy, their function and the principles behind their future study in patients with multiple sclerosis.

Keywords

multiple sclerosis urine neopterin

Get full access to this article

View all access options for this article.

References

Losseff NA et al. (1996) Progressive cerebral atrophy in multiple sclerosis: A serial MRI study . Brain 119: 2009-2020 .

Kidd D et al. (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis . J Neurol Neurosurg Psychiatry 60: 15-19 .

Losseff NA et al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression . Brain 119: 701-708 .

Gass A et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis . Ann Neurol 36: 62-67 .

van Walderveen MA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1- weighted) spin-echo images . Neurology 45: 1684-1690 .

Truyen et al. (1996) Accumulation of hypointense lesions (black-holes) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis . Neurology 47: 1469-1476 .

Davie CA et al. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions . Brain 117: 49-58 .

Martin R , McFarland HF. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis . Crit Rev Clin Lab Sci 32: 121-182 .

Svenningsson A et al. (1993) Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls . Ann Neurol 34: 155-161 .

10.

Mitrovic B et al. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro . Neuroscience 61: 575-585 .

11.

Lassmann H , Suchanek G , Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis . Ann Neurol 36: S42-S46 .

12.

Katz D et al. (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis . Ann Neurol 34: 661-669 .

13.

Rodriguez M , Sheithauer BW , Forbes G , Kelly PJ. (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosos . Mayo Clin Proc 68: 627-636 .

14.

Smith ME et al. (1993) Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions . Ann Neurol 33: 480-489 .

15.

Thompson AJ et al. (1992) Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration . Neurology 42: 60-63 .

16.

Wiebe S et al. (1992) Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis . Ann Neurol 32: 643-650 .

17.

Filippi M et al. (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis . Brain 118: 1601-1612 .

18.

Sharief MK , Hentges R. (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis . N Engl J Med 325: 467-472 .

19.

Thompson AJ et al. (1997) Primary progressive multiple sclerosis . Brain 120: 1085-1096 .

20.

Davie CA et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss . Brain 118: 1583-1592 .

21.

Rao SM et al. (1985) Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment . Arch Neurol 42: 678-682 .

22.

Comi G et al. (1993) Brain magnetic imaging correlates of cognitive impairment in multiple sclerosis . J Neurol Sci 15: S66-S73 .

23.

Schaarschmidt H , Prange HW , Reiber H. (1994) Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease . Stroke 25: 558-565 .

24.

Mokuno K et al. (1994) Prognostic value of CSF NSE and S-100b protein in Guillain-Barre syndrome . Acta Neurol Scand 89: 27-30 .

25.

Lamers KJB et al. (1995). CSF NSE, S-100 and MBP in neurological disorders . Acta Neurol Scand 92: 247-251 .

26.

Idiman et al. (1996) CSF and serum NSE in MS . Eur J Neurol 3 (Suppl 5): 116-116 .

27.

Cunningham RT , Morrow JL , Johnston CF , Buchanan KD. (1994) Serum NSE in patients with neurological disorders . Clin Chim Acta 230: 117-124 .

28.

Lycke J , Anderson O , Rosengren LE. (1996) Neurofilament in CSF: a potential marker of activity in MS . Eur J Neurol 3 (Suppl 5): 100-100 .

29.

Nagamatsu M et al. (1995) Cerebrospinal fluid levels of S- 100b and NSE in chronic inflammatory demyelinating polyneuropathy . Acta Neurol Scand 91: 483-487 .

30.

Michetti F , Massaro A , Murazio M. (1979) The nervous system-specific S-100b antigen in CSF of MS patients . Neurosci Lett 11: 171-175 .

31.

Michetti F , Massaro A , Russo G , Rigon G. (1980) The S- 100 antigen in CSF as a possible index of cell injury in the nervous system . J Neurol Sci 44: 259-263 .

32.

Missler U , Wandinger KP , Wiessmann M , Wesel K. (1996) Elevated plasma concentration of S-100 protein indicate acute exacerbation of multiple sclerosis . Meeting abstracts German Neuroscience meeting 1996.

33.

Eng LF. (1985) GFAp: the major protein of glial intermediate filaments in differentiated astrocytes . J Neuroimmunol 8: 203-214 .

34.

Crols R , Noppe M , Caers J , Lowenthal A. (1983) a=Albumin (GFA) as a marker of astrocytic involvement in human CSF . Neurochem Pathol 1: 91-102 .

35.

Noppe M , Crols R , Andries D , Lowenthal A. (1986) Determination in human CSF of GFAp, S-100 and MBP as indices of non-specific or specific central nervous tissue pathology . Clin Chima Acta 155: 143-150 .

36.

Rosengren LE , Lycke J , Andersen O. (1995) Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit . J Neurol Sci 133: 61-65 .

37.

Cohen SR , Herndon RM , McKhann GM. (1976) Radio-immunoassay of myelin basic protein in spinal fluid. An index of active demyelination . N Engl J Med 295: 1455-1457 .

38.

Whitaker JN. (1977) Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis . Neurology 27: 911-920 .

39.

Thomson AJ , Brazil J , Feighery C. (1985) Myelin basic-protein in multiple sclerosis . Acta Neurol Scand 72: 577-583 .

40.

Whitaker JN et al. (1995) Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis . Ann Neurol 38: 625-632 .